Alnylam Pharmaceuticals (ALNY) Debt/EBITDA US GAAP (year values) |
||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
Debt/EBITDA | 1.42 | 1.84 | 2.17 | 0.94 | -0.94 | 11.2 | ||
Changes by years, y/y, % | +13% | +29% | +18% | -57% | -200% |
Alnylam Pharmaceuticals. Debt/EBITDA
Alnylam Pharmaceuticals. Debt/EBITDA, changes, %
Alnylam Pharmaceuticals (ALNY) Debt/EBITDA US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
Debt/EBITDA | 2.97 | -0.85 | -2.00 | 0.67 | 11.2 | 11.2 | ||
Changes by years, y/y, % | +136% | -171% | -292% | -28% | +278% | |||
Changes by quarters, q/q, % | +219% | -129% | +134% | -134% | +1 571% |